Breakfast Brief Dr. Solange Peters
Interviewpartner:
Prof. Solange Peters, MD, PhD
Redaktion:
Dr. Gerhard Emrich
Produktion:
Oliver Eberhardt
Warning : Undefined property: medonline\theme\lib\templates\MoSingle::$ID in
/appl/www/htdocs/medonline/web/app/themes/mydailyapplenew/templates/entry-meta-video.php on line
56
veröffentlicht am Warning : Undefined property: medonline\theme\lib\templates\MoSingle::$postId in /appl/www/htdocs/medonline/web/app/themes/mydailyapplenew/templates/entry-meta-video.php on line 59
Prof. Solange Peters, head of the Medical Oncology Service, Chair of Thoracic Oncology, Oncology Department, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland, presents the newest data on immunotherapy in NSCLC.
Abstracts presented:Kowanetz M et al., abstract CT076: IMpower150: Efficacy of atezolizumab (atezo) plus bevacizumab (bev) and chemotherapy (chemo) in 1L metastatic nonsquamous NSCLC (mNSCLC) across key subgroups Gandhi L et al., abstract CT075: KEYNOTE-189: Randomized, double-blind, phase 3 study of pembrolizumab (pembro) or placebo plus pemetrexed (pem) and platinum as first-line therapy for metastatic NSCLC Hellmann MD et al., abstract CT077: Nivolumab (nivo) + ipilimumab (ipi) vs platinum-doublet chemotherapy (PT-DC) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): initial results from CheckMate 227 Forde PM et al., abstract CT079: Neoadjuvant PD-1 blockade in resectable lung cancer